|
⚲
|
| Keyboard |
| Cortexyme Inc | |
|---|---|
| Ticker | QNCX |
| CIK # | 0001662774 |
| CUSIP | 22053A107 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 269 East Grand Ave, South San Francisco, CA 94080 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Quince Therapeutics Inc | 2025-07-01 | 11.5 M | Exemption: 506(b) · Remaining: $10,408,314 · Duration: One year or less · Commission: $689,299 · Revenue: Decline to Disclose |
| Cortexyme Inc | 2018-05-31 | 84.5 M | Exemption: 506(b) · Remaining: $1,099,997 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001662774] | 10-K | |
| [0001662774] | 10-Q | |
| [0001662774] | 3 | |
| [0001662774] | 4 | |
| [0001662774] | 5 | |
| [0001662774] | 8-K | |
| [0001662774] | D | |
| [0001662774] | SC 13D | |
| [0001662774] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Thye Dirk
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 1,000,000 | $0.00 | |
|
Ryan Charles S
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 200,000 | $0.00 | |
|
Hannah Brendan
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 365,000 | $0.00 | |
|
Senner Christopher J
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 21,810 | $0.00 | |
|
McLoughlin Margaret
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 19,547 | $0.00 | |
|
Lamond David
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 29,423 | $0.00 | |
|
Bray June
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 18,724 | $0.00 | |
|
Benatti Luca
Common Stock
|
2025-12-26 | Sell | 50,000 | $3.47 | 173,500 |
|
Thye Dirk
Common Shares
|
2025-12-10 | Gift | 739,885 | $0.00 | |
|
Thye Dirk
Common Shares
|
2025-12-10 | Gift | 739,885 | $0.00 | |
|
Hannah Brendan
Employee Stock Option (Right to Buy) · derivative
|
2025-12-05 | Option exercise | 25,280 | $0.00 | |
|
Hannah Brendan
Common Shares
|
2025-12-05 | Option exercise | 25,280 | $0.94 | 23,763 |
|
Hannah Brendan
Common Shares
|
2025-12-05 | Option exercise | 2,271 | $0.55 | 1,249 |
|
Hannah Brendan
Employee Stock Option (Right to Buy) · derivative
|
2025-12-05 | Option exercise | 2,271 | $0.00 | |
|
Hannah Brendan
Warrants · derivative
|
2025-06-18 | Grant | 37,736 | $0.13 | 4,906 |
|
Hannah Brendan
Common Shares
|
2025-06-18 | Grant | 37,736 | $1.20 | 45,283 |
|
Ryan Charles S
Common Shares
|
2025-06-18 | Grant | 7,548 | $1.20 | 9,058 |
|
Thye Dirk
Common Shares
|
2025-06-18 | Grant | 150,944 | $1.20 | 181,133 |
|
Ryan Charles S
Warrants · derivative
|
2025-06-18 | Grant | 7,548 | $0.13 | 981 |
|
Thye Dirk
Warrants · derivative
|
2025-06-18 | Grant | 150,944 | $0.13 | 19,623 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 41 | 15,010,119 |
| 2025-12-31 | 67 | 20,254,303 |
| 2025-09-30 | 45 | 12,302,010 |
| 2025-06-30 | 43 | 7,761,669 |
| 2025-03-31 | 37 | 5,241,783 |
| 2024-12-31 | 39 | 5,965,691 |
| 2024-09-30 | 34 | 5,201,017 |
| 2024-06-30 | 44 | 6,265,274 |
| 2024-03-31 | 47 | 7,308,801 |
| 2023-12-31 | 45 | 7,461,776 |
| 2023-09-30 | 43 | 6,587,288 |
| 2023-06-30 | 44 | 9,018,510 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |